https://www.selleckchem.com/pr....oducts/biricodar.htm
(10.5% to 18.7% [8.2% difference]; P .001). The odds of eligibility were lower for women compared with men (adjusted odds ratio [AOR], 0.88; 95% CI, 0.79-0.99; P = .04) and for Black (AOR, 0.43; 95% CI, 0.33-0.56; P .001) and Hispanic populations (AOR, 0.70; 95% CI, 0.62-0.80; P .001) compared with the White population. The revised USPSTF guideline may likely increase lung cancer screening rates for female, Black, and Hispanic populations. However, despite these potential improvements, lung cancer screening inequities m
Gefällt mir
Kommentar
Teilen
